Gene · 6557
Papers2,541
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,541
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SLC26A9 in airways and intestine: secretion or absorption? | Channels (Austin) | 2023 | 36866602 | PubTator, text mining | PubMed |
| Characterization of Continuous Transcriptional Heterogeneity in High-Risk Blastemal-Type Wilms' Tumors Using Unsupervised Machine Learning. | Int J Mol Sci | 2023 | 36834944 | PubTator, text mining | PubMed |
| The "3Ds" of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening. | Cells | 2023 | 36831216 | PubTator, text mining | PubMed |
| Metformin Alleviates Diabetes-Associated Hypertension by Attenuating the Renal Epithelial Sodium Channel. | Biomedicines | 2023 | 36830842 | PubTator, text mining | PubMed |
| Systematic Assessment of Protein C-Termini Mutated in Human Disorders. | Biomolecules | 2023 | 36830724 | PubTator, text mining | PubMed |
| Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report. | Open Med (Wars) | 2023 | 36820062 | PubTator, text mining | PubMed |
| Shockwaves and the Rolling Stones: An Overview of Pediatric Stone Disease. | Kidney Int Rep | 2023 | 36815103 | PubTator, text mining | PubMed |
| Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma. | Comput Math Methods Med | 2023 | 36785674 | PubTator, text mining | PubMed |
| Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system. | Am J Physiol Cell Physiol | 2023 | 36779666 | PubTator, text mining | PubMed |
| Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock. | J Clin Med | 2023 | 36769755 | PubTator, text mining | PubMed |
| Lateral Diffusion of NKCC1 Contributes to Chloride Homeostasis in Neurons and Is Rapidly Regulated by the WNK Signaling Pathway. | Cells | 2023 | 36766805 | PubTator, text mining | PubMed |
| Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer. | Cancers (Basel) | 2023 | 36765747 | PubTator, text mining | PubMed |
| Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle. | Am J Physiol Renal Physiol | 2023 | 36727946 | PubTator, text mining | PubMed |
| Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease. | J Adv Res | 2023 | 36725183 | PubTator, text mining | PubMed |
| Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids. | Proc Natl Acad Sci U S A | 2023 | 36724260 | PubTator, text mining | PubMed |
| Structure of a 28.5 kDa duplex-embedded G-quadruplex system resolved to 7.4 Å resolution with cryo-EM. | Nucleic Acids Res | 2023 | 36715343 | PubTator, text mining | PubMed |
| The Role of Macula Densa Nitric Oxide Synthase 1 Beta Splice Variant in Modulating Tubuloglomerular Feedback. | Compr Physiol | 2023 | 36715280 | PubTator, text mining | PubMed |
| Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin? | Curr Opin Nephrol Hypertens | 2023 | 36683539 | PubTator, text mining | PubMed |
| Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive Targeting. | Pharmaceutics | 2023 | 36678805 | PubTator, text mining | PubMed |
| Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine. | Pharmaceutics | 2023 | 36678791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6557/papers?page=15